You are thirty-three, a physician trained at St Mary's Hospital Medical School in London, and you are serving in a field hospital on the Western Front under Almroth Wright, one of the pioneers of vaccine therapy. You are watching men die of infected wounds. The injuries from artillery and shrapnel are severe, and the bacterial infections that follow them are frequently more lethal than the initial wounds. Surgeons and medics apply antiseptics — carbolic acid, boric acid, hydrogen peroxide — directly to wounds. This is standard practice. You begin to suspect it is making things worse.
The problem, as you will analyze it, is that antiseptics are not selective: they kill bacteria, but they also destroy the white blood cells that the body deploys to fight infection. In wounds with complex geometry — shrapnel wounds, shell wounds with deep irregular channels — the antiseptic cannot reach the bacteria deep in the tissue, but it can destroy the leucocytes at the wound's accessible surfaces. You are watching a treatment harm patients. You begin collecting evidence. Wright is skeptical of your analysis. The evidence accumulates regardless.
Fleming observes that antiseptics may be harming rather than helping wounded soldiers. What does this require of him?
You watch soldiers die of infected wounds on the Western Front while the antiseptics meant to save them destroy the white blood cells that are the body's only real defense. You begin collecting evidence. Your superior is skeptical. The evidence accumulates regardless.
Fleming on antiseptics: Fleming and Wright published papers arguing that antiseptics, in deep wounds, were doing more harm than good. The papers were largely ignored during the war — too disruptive to established practice, too uncomfortable to act on. The same mistake was repeated in World War II, until penicillin made the antiseptic debate moot. Fleming's wartime experience was not wasted: it gave him a precise understanding of what a truly useful antibacterial agent needed to do — kill bacteria without harming human tissue. This understanding is what made him recognize what he was looking at in 1928.You have a cold. This is professionally useful: you add a drop of nasal mucus to a culture of bacteria and observe the result. The mucus kills some of the bacteria. You investigate the mechanism and discover that it contains an enzyme — you name it lysozyme — that breaks down the cell walls of certain bacteria. You have discovered a naturally occurring antibacterial substance in the human body. It is not clinically powerful enough to be a medicine — it kills only relatively harmless bacteria — but it proves a principle: the body contains substances that selectively destroy bacteria without harming human tissue. You write up the finding and publish.
The paper receives little attention. Lysozyme is a curiosity, not a medical breakthrough. You file it away. You continue your research. The principle you have proved — selective antibacterial action — is the thing you will need to recognize penicillin when it appears.
Fleming's lysozyme discovery receives little attention. Why does it matter anyway?
You have a cold in 1922 and add a drop of your own nasal mucus to a bacterial culture to see what happens. What you find — an enzyme that kills bacteria without harming human tissue — proves the principle that leads directly to penicillin six years later.
Prepared minds: Louis Pasteur said "chance favors only the prepared mind." Fleming's preparation was specific: he had spent years thinking about what an ideal antibacterial agent would look like (kills bacteria, spares human cells, works in the complex environment of a wound), and he had developed the technique of looking at contaminated cultures rather than discarding them, because contamination could be informative. When the penicillin mold landed on his Staphylococcus plate in 1928, the prepared mind saw a clear zone of dead bacteria around it and asked why — rather than noting contamination and discarding the plate, which is what an unprepared mind would have done.Late August 1928. You have gone on holiday, leaving some Staphylococcus culture plates on your bench — an untidy habit that several colleagues find irritating. The London summer has been unusually cool and then warm. When you return in early September and begin sorting through the plates before discarding them, one plate catches your attention. A mold has contaminated it — a common enough event in microbiology laboratories — but around the mold, in a clear halo, the Staphylococcus colonies are dead or dying. A contaminating mold is killing your bacteria.
You call over a colleague, D.M. Pryce, and say: "That's funny." You do not discard the plate. You photograph it. You culture the mold. You identify it as Penicillium notatum. You test its antibacterial properties. You find that even heavily diluted, it kills Staphylococci and other harmful bacteria but does not harm white blood cells. You name the antibacterial substance penicillin. You publish in 1929. The paper receives almost no interest from the clinical community.
Fleming sees a contaminated plate and says "That's funny." What made this observation historically decisive?
You return from holiday in September 1928, sort through old culture plates before discarding them, and say "That's funny" to a colleague instead of throwing the plate away. That single act of curiosity will save an estimated 200 million lives.
The accident and the observation: Several other bacteriologists may have seen similar contamination effects before 1928 and missed them. The role of luck in Fleming's discovery is real but limited: the luck was in the contamination occurring. The science was in recognizing what it meant. Fleming's laboratory notebooks show that he did not just notice the halo — he immediately hypothesized a diffusible antibacterial substance, designed experiments to test this, measured the inhibition zones quantitatively, and tested the substance's effects on multiple bacterial species and on leucocytes. The accidental contamination was the beginning; the rigorous investigation was the discovery.Your paper "On the Antibacterial Action of Cultures of a Penicillium" is published in the British Journal of Experimental Pathology in June 1929. You describe penicillin's antibacterial properties, its apparent non-toxicity to leucocytes, and its potential therapeutic use. You also note that penicillin is unstable — it breaks down quickly and is difficult to extract in purified form. You make several attempts to produce penicillin in a stable, concentrated form suitable for clinical use. You are not a chemist, and the purification problem defeats you. In 1934, you effectively stop active research on penicillin.
The paper sits largely unread for a decade. In 1939, Howard Florey and Ernst Chain at Oxford read it and begin systematic work on producing penicillin in medically useful form. By 1941 they have purified it sufficiently to treat patients. By 1944, with American industrial funding, it is produced on a large enough scale to treat D-Day casualties. Fleming's discovery becomes the antibiotic age. He learns about the Oxford work from newspaper reports, which have, by this point, begun attributing the discovery entirely to him.
Fleming publishes penicillin findings but cannot solve the purification problem and stops active research. Is this a failure?
You publish the penicillin paper in 1929, try for five years to purify a stable form, fail, and stop active research. Florey and Chain read your paper a decade later and succeed where you couldn't. The fifteen-year gap is not failure — it is science advancing through the division of labor.
Fleming's role and limits: Several historians have argued that Fleming didn't push hard enough for penicillin's development in the 1930s — that he could have found chemists to work on purification if he had tried. Fleming's defenders note that the purification problem was genuinely difficult: even Florey and Chain, with full Oxford chemistry department support and eventually American industrial backing, took years to solve it. The fifteen-year gap between discovery and clinical use is attributable to technical difficulty more than neglect. What is not in doubt is that Fleming's 1929 paper was the foundation of everything that followed.Howard Florey and Ernst Chain have purified penicillin and begun human trials. The first patient is Albert Alexander, a policeman in Oxford who scratched his face on a rose thorn and whose resulting infection has spread to his entire face, scalp, and lungs. He is dying. On February 12, 1941, he receives the first injection of purified penicillin. Within twenty-four hours his temperature drops and he begins to improve. They run out of penicillin after five days (they were recycling it from his urine), and Alexander eventually dies. But the proof of principle is complete: penicillin works in humans.
Fleming visits Oxford to see the work. He is generous about Florey and Chain's contribution; they are less generous about his. In the press coverage that follows, newspapers focus on Fleming's original discovery — the story of the contaminated petri dish is more dramatic than the Oxford chemistry work — and Fleming becomes the face of penicillin. Florey finds this deeply irritating. The Nobel Committee, when it awards the prize in 1945, splits it three ways.
The Nobel Prize is split equally between Fleming, Florey, and Chain. Is this allocation fair?
The 1945 Nobel splits three ways: Fleming, Florey, Chain. Florey finds this deeply irritating. The argument about who deserves the most credit will not be settled. The answer that survives is that all three steps — discovery, development, clinical implementation — were necessary, so all three scientists were necessary.
The three-way split: The priority dispute between Fleming and Florey became one of the most public disputes in the history of science. Florey's position — that the Oxford team did the real work — has significant merit. Fleming's position — that the discovery is what everything else depends on — also has merit. In practice, the Nobel split is the right answer: no single step in the chain from observation to medicine is dispensable, and the committee's decision to divide the prize reflects this accurately. Fleming's public profile was and remains higher than Florey's and Chain's, which continues to rankle among historians of science — but public recognition and scientific priority are different things.December 1945. Nobel Prize in Physiology or Medicine. You, Howard Florey, and Ernst Chain. In your Nobel lecture, you are careful to credit Florey and Chain's work on development; you describe your own role accurately. In your public interviews, you warn — repeatedly and specifically — about the danger of using penicillin in insufficient doses. If patients take too little penicillin, or stop too early, the bacteria will survive in reduced numbers and those survivors will be the ones with natural resistance. The resistant strains will multiply. You are predicting antibiotic resistance in 1945, two years after penicillin becomes widely available.
Your Nobel lecture warning about resistance is the most prescient public statement in the history of medicine. By 2025, antibiotic-resistant infections are estimated to kill 1.3 million people per year. Fleming knew this was coming before the age of antibiotics had properly begun.
Fleming warns about antibiotic resistance in his Nobel lecture. What does this warning require him to say to a world that is celebrating penicillin as a miracle cure?
At your Nobel lecture in December 1945, you warn a world celebrating penicillin as a miracle cure that patients who take too little will breed the resistant strains that kill the next patient. By 2025, antibiotic-resistant infections kill 1.3 million people per year. You were right about everything.
Fleming's resistance warning: He said explicitly in his Nobel lecture: "The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant." This was not an obvious prediction in 1945 — most public and medical commentary was celebrating penicillin as a definitive solution to bacterial infection. Fleming's warning was based on his understanding of bacterial evolution and selection: bacteria that survive a partial dose are, by definition, those with natural resistance, and they will reproduce. The warning was correct in every detail.You are now Sir Alexander Fleming (knighted 1944) and one of the most recognizable scientists in the world. You travel widely, give lectures, accept honorary degrees — you will receive twenty-five honorary degrees from universities across Europe and America. Your second wife is Amalia Coutsouris-Voureka, a Greek bacteriologist who was one of your research team. You continue to work at St Mary's until near the end of your life.
What you watch, in these final years, is the antibiotic age you started: the discovery and development of streptomycin (1943), chloramphenicol (1947), tetracycline (1948), erythromycin (1952). A revolution in medicine that has fundamentally changed the relationship between humans and infectious disease. Before penicillin, a scratch on a rose thorn could kill a man. After penicillin, infections that had killed for all of human history became treatable. You know exactly how large this is. You are also watching the first resistant strains appear, exactly as you predicted.
Fleming sees the antibiotic revolution he helped create but also the emerging resistance problem. How does he understand his own place in history?
You are Sir Alexander Fleming, collecting your twenty-fifth honorary degree, one of the most recognizable scientists alive. You keep telling interviewers that luck played a central role in the discovery. You are one of the few Nobel laureates precise enough to mean it — and accurate enough to specify exactly what the luck was and what it was not.
Fleming's self-assessment: He repeatedly told interviewers that luck played a central role in the penicillin discovery, and he was specific about what the luck was: the mold contaminating the plate rather than some other contaminant, the unusual London summer temperatures, his own decision to look at old plates before discarding them rather than simply throwing them away. He distinguished the luck (which was real) from the preparation (which allowed the luck to be productive). His Nobel lecture is notable for its precision about both the science and its own limitations. He was not a modest man — his public profile was enormous and he cultivated it — but he was an accurate one.March 11, 1955. You die of a heart attack at your home in London. You are seventy-three. Howard Florey sends a telegram of condolence to your wife. They have never fully reconciled the question of credit. It doesn't matter anymore. By the time of your death, penicillin and the antibiotics it inspired have saved an estimated eighty million lives. By 2025, the number will be estimated at two hundred million. No single discovery in the history of medicine has saved more people.
The contaminated petri dish you photographed in September 1928 rather than discarding — because "that's funny" — is one of the most consequential acts of observation in history. You knew, when you saw it, that the clear halo of dead bacteria meant something. You were right.
Fleming's discovery saved more lives than perhaps any single observation in history. What is the most important lesson of his career for how science works?
Every bacteriologist working in London in 1928 could have found that contaminated plate and thrown it away. You found it, photographed it, and asked why the bacteria were dying in a clear halo around the mold. The contamination was ordinary. What made it a discovery was that you knew what you were looking at.
Pasteur's principle confirmed: "Chance favors only the prepared mind" — said about Pasteur himself, but applicable to Fleming with precision. The contamination of culture plates was common. The prepared mind — shaped by specific experiences of antiseptic failure in wartime, by lysozyme research, by years of thinking about what a useful antibacterial substance would have to do — was uncommon. The observation that the halo was significant rather than routine contamination was not luck: it was the application of accumulated knowledge to a chance event. This is how most major scientific discoveries actually happen, and Fleming's case illustrates it with unusual clarity.Life Complete
Alexander Fleming · 1881–1955
You scored correct decisions
"One sometimes finds what one is not looking for."
— Alexander Fleming